L'actinomycose est une maladie chronique suppurative granulomateuse d'origine infectieuse responsable d'un syndrome tumoral. La localisation pelvienne est rare et souvent associée, chez la femme, au port au long court du dispositif intra-utérin (DIU). Le diagnostic préopératoire n'est possible que dans 17% des cas. Nous rapportons trois observations, d'actinomycose pelvienne pseudo tumorale compliquées chez des femmes porteuses de DIU, qui illustrent le rôle de ce moyen de contraception dans la genèse de cette pathologie ainsi que les difficultés de prise en charge.
Granulomatous mastitis is indeed a rare affliction, but it can constitute a veritable diagnosis and treatment predicament for several reasons. The etiology of this disease remains shrouded in mystery and the treatment depends on the gravity and extension of the lesions, ranging from corticosteroids to surgical excision with an important recurrence rate. We present the case of 40-year-old woman with granulomatous mastitis for which clinical and radiological remission was obtained via medical treatment.
Solitary fibrous tumors of the pelvis are rare. We report the case of a 32-years-old patient who presented with abdominopelvic mass. The imaging studies showed a right adnexal mass of more than 10 cm. Exploratory laparotomy revealed a 20 cm mass at the Douglas pouch which was adhered to the posterior wall of the uterus. Complete resection of the mass was performed. Histological analysis showed a spindle cell undifferentiated tumor whose morphological and immunohistochemical profile are consistent with solitary fibrous tumor. It is important to know that although these tumors are rare, their evolution can be pejorative. Therefore, long-term followup should be recommended.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.